Robeco Institutional Asset Management B.V. Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Robeco Institutional Asset Management B.V. increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 42.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 20,586 shares of the medical device company's stock after purchasing an additional 6,102 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Cooper Companies were worth $1,892,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of COO. Ashton Thomas Securities LLC purchased a new stake in shares of Cooper Companies in the third quarter valued at about $25,000. Covestor Ltd lifted its stake in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after purchasing an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. grew its holdings in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $49,000. Finally, Friedenthal Financial acquired a new stake in shares of Cooper Companies during the 3rd quarter worth about $50,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on COO. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Citigroup dropped their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research report on Friday, December 6th. Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $117.00.

Cooper Companies Stock Performance

NASDAQ COO traded up $1.03 during trading on Wednesday, reaching $96.33. The company's stock had a trading volume of 109,664 shares, compared to its average volume of 1,314,430. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The firm has a market cap of $19.23 billion, a price-to-earnings ratio of 49.45, a P/E/G ratio of 2.45 and a beta of 1.00. The business's fifty day moving average price is $95.50 and its 200-day moving average price is $99.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same period last year, the firm earned $0.87 EPS. The firm's revenue for the quarter was up 9.8% on a year-over-year basis. As a group, analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.